Nanded university gets Indian patent for nano drug delivery technology for tuberculosis
What Happened
Nanded's Swami Ramanand Teerth Marathwada University (SRTMUN) has received a 20-year Indian patent for a nanostructured drug delivery system designed to improve the effectiveness of poorly water-soluble tuberculosis medicines. The technology aims to enhance how anti-TB drugs are delivered and absorbed in the body, potentially improving treatment outcomes.
Key Takeaways
The patent marks a significant research milestone that could help overcome a major challenge in TB treatment: delivering poorly soluble medicines more effectively. The innovation strengthens India's growing capabilities in nanomedicine and drug-delivery research.